
SUPPLY ISSUE Methylphenidate Tablets
There is a global shortage of ADHD medicines, as well as significant increase in demand. Availability changes by the day. Click the following link to

There is a global shortage of ADHD medicines, as well as significant increase in demand. Availability changes by the day. Click the following link to
Chiesi New Zealand Ltd have advised they are out of stock of the above product with no resupply ETA available. Click here to access the

Supplier (Douglas) has advised Pharmac that there will be a supply issue from late December 2025, with anticipated resupply April 2026. Click the following link
Eli Lilly will launch their Weight Loss product – Mounjaro into the New Zealand effective from 11 February 2026. This will provide practitioners with two

Supplier (Douglas) has advised Pharmac that there will be a supply issue from late December 2025, with anticipated resupply April 2026. Click the following link
Click here to access the analysis for Lorstat Tab 80mg. Viatris have recently had an Out-of-Stock situation with the Lorstat Tab 80mg 500 pack Pharmacode
Supplier has advised Pharmac of an out-of-stock situation from late January 2026 Anticipated ETA– mid to late March 2026, to be confirmed. Click the following

Click here to access the latest Nutricia Stock Update Report. Click the link below to access PHARMAC website information. https://pharmac.govt.nz/medicine-funding-and-supply/medicine-notices/nutricia/ In association with Nutricia, we

MAXhealth had notified Pharmac of a supply issue affecting all three strengths of Octreotide Injection 5 x 1ml Please click the link below to access
ProPharma wish to advise that they are now stocking two key private market treatments for migraine. Emgality (Galcanezumab) Auto Injector 120mg 1ml single unit, Pharmacode
Supplier has advised Pharmac of a supply issue of the above-mentioned products. Click the below link to access Pharmac Website information https://www.pharmac.govt.nz/medicine-funding-and-supply/medicine-notices/ticagrelor Anticipated ETA– unknown.
Pharmac has awarded the Tender to an alternative brand which will be listed from 1 April 2026 and move to Principal Supply Status effective from
Rex Medical have advised Pharmac they can no longer supply this product into New Zealand. Stock is depleted. Pharmac listed from 1 June 2025 under